These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36382110)

  • 1. Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies.
    Mikolajewicz N; Khan S; Trifoi M; Skakdoub A; Ignatchenko V; Mansouri S; Zuccatto J; Zacharia BE; Glantz M; Zadeh G; Moffat J; Kislinger T; Mansouri A
    Neurooncol Adv; 2022; 4(1):vdac161. PubMed ID: 36382110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
    Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
    Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
    Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
    J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours.
    Landry AP; Zuccato JA; Patil V; Voisin MR; Wang JZ; Ellenbogen Y; Gui C; Ajisebutu A; Kislinger T; Nassiri F; Zadeh G
    J Neurooncol; 2024 Sep; 169(2):233-239. PubMed ID: 39102117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.
    Miller AM; Szalontay L; Bouvier N; Hill K; Ahmad H; Rafailov J; Lee AJ; Rodriguez-Sanchez MI; Yildirim O; Patel A; Bale TA; Benhamida JK; Benayed R; Arcila ME; Donzelli M; Dunkel IJ; Gilheeney SW; Khakoo Y; Kramer K; Sait SF; Greenfield JP; Souweidane MM; Haque S; Mauguen A; Berger MF; Mellinghoff IK; Karajannis MA
    Neuro Oncol; 2022 Oct; 24(10):1763-1772. PubMed ID: 35148412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors.
    Kopkova A; Sana J; Machackova T; Vecera M; Radova L; Trachtova K; Vybihal V; Smrcka M; Kazda T; Slaby O; Fadrus P
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
    Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
    BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
    Mikolajewicz N; Yee PP; Bhanja D; Trifoi M; Miller AM; Metellus P; Bagley SJ; Balaj L; de Macedo Filho LJM; Zacharia BE; Aregawi D; Glantz M; Weller M; Ahluwalia MS; Kislinger T; Mansouri A
    J Clin Oncol; 2024 Jun; 42(16):1961-1974. PubMed ID: 38608213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
    Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
    Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered CSF Proteomic Profiling of Paediatric Acute Lymphocytic Leukemia Patients with CNS Infiltration.
    Mo F; Ma X; Liu X; Zhou R; Zhao Y; Zhou H
    J Oncol; 2019; 2019():3283629. PubMed ID: 31186631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
    Macron C; Lane L; Núñez Galindo A; Dayon L
    J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Associated Natural Killer Cell EVs Generating Tumour-Specific Signatures: Noninvasive GBM Liquid Biopsy with Self-Functionalized Quantum Probes.
    Ishwar D; Haldavnekar R; Das S; Tan B; Venkatakrishnan K
    ACS Nano; 2022 Jul; 16(7):10859-10877. PubMed ID: 35816089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.
    Teplyuk NM; Mollenhauer B; Gabriely G; Giese A; Kim E; Smolsky M; Kim RY; Saria MG; Pastorino S; Kesari S; Krichevsky AM
    Neuro Oncol; 2012 Jun; 14(6):689-700. PubMed ID: 22492962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APRIL and BAFF: novel biomarkers for central nervous system lymphoma.
    Mulazzani M; Huber M; Borchard S; Langer S; Angele B; Schuh E; Meinl E; Dreyling M; Birnbaum T; Straube A; Koedel U; von Baumgarten L
    J Hematol Oncol; 2019 Oct; 12(1):102. PubMed ID: 31615554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
    Samuel N; Remke M; Rutka JT; Raught B; Malkin D
    J Neurooncol; 2014 Jun; 118(2):225-238. PubMed ID: 24771250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
    Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
    Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme.
    Chagovetz AA; Jensen RL; Recht L; Glantz M; Chagovetz AM
    J Neurooncol; 2011 Dec; 105(3):499-506. PubMed ID: 21720810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
    Yan W; Xu T; Zhu H; Yu J
    Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.